Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
51037-30-0
Purity
95%
Acipimox is a niacin derivative used as a hypolipidemic agent. Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a modest reduction in LDL and increase in HDL. It is used in Fredrickson type IIb and type IV hyperlipoproteinemia.
Properties
Name
Acipimox
Smiles
CC=1C=NC(=C[N+]1[O-])C(=O)O
Targets
Please log in to see this information
SDS
2-carboxy-5-methylpyrazine-4-oxide | 5-methylpyrazine-2-carboxylic acid-4-oxide | 5-methylpyrazinecarboxylic acid 4-oxide | acipimox
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
2-carboxy-5-methylpyrazine-4-oxide | 5-methylpyrazine-2-carboxylic acid-4-oxide | 5-methylpyrazinecarboxylic acid 4-oxide | acipimox
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.